Back to results
US 2003/0199550 A1Published application
Substituted cyclohexane derivatives
AssigneeHoffmann-La Roche Inc.
InventorsJean Ackermann, Johannes Aebi, Henrietta Dehmlow, Georges Hirth, Hans-Peter Maerki, Olivier Morand
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of formula (I) 1 wherein A1, A2, A3, A4, A5, A6, A7, A8, A9, A10, U, V, W, m, n and p are as indicated in the specification, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia and hyperlipemia.
Claims33
A compound of formula (I)
- 18
- wherein
- U is O or a lone pair,
- V is a single bond, O, S, —CH2—, —CH═CH—, —CH═CH—CH2—O—, or —C≡C—,
- W is CO, COO, CONR1, CSO, CSNR1, SO2, or SO2NR1,
- m and n independently from each other are from 0 to 7 and m+n is from 0 to 7, with the proviso that m is not 0 if V is O or S,
- A1 is hydrogen, lower-alkyl, hydroxy-lower-alkyl, or lower-alkenyl,
- A2 is cycloalkyl, cycloalkyl-lower-alkyl, lower-alkenyl, lower-alkynyl, heteroaryl, substituted heteroaryl, or lower-alkyl optionally substituted by R2, or
- A1 and A2 are bonded to each other to form a ring with the N atom to which they are attached, and —A1—A2— is lower-alkylene or lower-alkenylene, optionally substituted by R2, in which one —CH2— group of
- —A1—A2— can optionally be replaced by NR3, S, or O, or —A1—A2— is —CH═N—CH═CH— which can optionally be substituted by lower-alkyl,
- A3 and A4 independently from each other are hydrogen or lower-alkyl, or
- A3 and A4 are bonded to each other to form a ring together with the carbon atom to which they are attached and —A3—A4— is —(CH2)2-5—,
- A5, A6, A7 and A8 independently from each other are hydrogen or lower-alkyl,
- A9 is hydrogen, lower-alkyl, lower-alkenyl, or aryl-lower-alkyl,
- A10 is lower-alkyl, cycloalkyl, aryl, substituted aryl, aryl-lower-alkyl, substituted aryl-lower alkyl, heteroaryl, substituted heteroaryl, heteroaryl-lower-alkyl, or substituted heteroaryl-lower alkyl,
- p is 0 or 1,
- R2 is hydroxy, hydroxy-lower-alkyl, lower-alkoxy, lower-alkoxycarbonyl, N(R4,R5), thio-lower-alkoxy or halogen,
- R1, R3, R4 and R5 independently from each other are hydrogen or lower-alkyl, substituted aryl and substituted heteroaryl are aryl and heteroaryl, respectively, substituted by 1 to 3 substituents independently selected from the group consisting of lower-alkyl, lower-alkynyl, dioxo-lower-alkylene (forming e.g. a benzodioxyl group), halogen, hydroxy, CN, CF3, NH2, N(H, lower-alkyl), N(lower-alkyl)2, aminocarbonyl, carboxy, NO2, lower-alkoxy, thio-lower-alkoxy, lower-alkylcarbonyl, lower-alkylcarbonyloxy, lower-alkoxycarbonyl, phenyl, and phenyloxy,
- and pharmaceutically acceptable salts thereof,
- with the proviso that the compound of formula (I) is not trans-naphthalene-1-sulfonic acid methyl-(4-methylaminomethyl-cyclohexylmethyl)-amide.
17 more elements
12 The compound according to claim 10, wherein n is 0.
A compound of formula (I)
- 19
- wherein
- U is a lone pair,
- V is —CH2—, —CH═CH—, or —C≡C—,
- W is COO or SO2,
- m and n independently from each other are from 0 to 3 and m+n is from 0 to 3,
- A1 is hydroxy lower-alkyl, or lower-alkyl,
- A2 is hydroxy lower-alkyl or lower-alkyl, or
- A1 and A2 are bonded to each other to form a ring with the N atom to which they are attached, and —A1—A2— is lower-alkylene,
- A3 and A4 are each hydrogen,
- A5, A6, A7 and A8 are each hydrogen,
- A9 is lower-alkyl,
- A10 is phenyl substituted with chlorine or —CF3,
- p is 0 or 1,
- and pharmaceutically acceptable salts thereof.
12 more elements
Dependencies are inferred from the claim text.